中文 | English

Infertility? From the “Three-Parent” IVF Trialed for Infertility to current market trend discussion.
Are you ready?

Event details

DATE
Friday October 18, 2019

VENUE
Webex

TIME
3:00 PM - 4:00 PM

RSVP
This is a FREE event
VIP tckets priority for Lingmed current clients
Please RSVP by October 17, 2019
PRESENTERS
Lingling Cao, CEO & Founder
Hank Wang, Medical advisor

REGISTER
+86 21 5386 3003

Agenda

15:00 - 15:10Linkedbio services & projects introductions    by LingLing Cao
15:10 - 15:45Infertility? From the “Three-Parent” IVF Trialed for Infertility to current market trend discussion.    by Hank Wang
15:45 - 15:55Panel discussions  
15:55 - 16:00Q&A  

Presenters

Lingling Cao
CEO & Founder
Lingling has more than a decade of experience in the healthcare industry, especially in deal-making. She founded Lingmed, which aims to support BD professionals to make better decisions with intelligence databases and EU-China cross-border deals. Prior to her venture at Lingmed, she was a senior BD manager for Eli Lilly in Shanghai and a consultant for McKinsey in Germany

Hank Wang
Medical advisor
Dr Wang holds a PhD degree on Medicinal Chemistry from Peking University, has a Postdoc experience in University of Missouri-Saint Louis, and worked as a Postdoc Fellow in Auburn University. Hank Wang has more than 10 years’ experience in pharmaceuticals industry. Hank has worked as Vice President and President of R&D at Beijing Haiyan Pharmaceutical Co., Ltd. - Yangtze River Pharmaceutical Group. Dr Wang advises Lingmed on innovative assets evaluation for China market
Download meeting reports
©Copyright 2013 - 2019 Lingmed Limited